Viral Pneumonia: From Influenza to COVID-19

Catia Cilloniz, Guinevere Dy-Agra, Rodolfo S. Pagcatipunan, Antoni Torres

Producción científica: Artículo CientíficoArtículo originalrevisión exhaustiva


Respiratory viruses are increasingly recognized as a cause of community-acquired pneumonia (CAP). The implementation of new diagnostic technologies has facilitated their identification, especially in vulnerable population such as immunocompromised and elderly patients and those with severe cases of pneumonia. In terms of severity and outcomes, viral pneumonia caused by influenza viruses appears similar to that caused by non-influenza viruses. Although several respiratory viruses may cause CAP, antiviral therapy is available only in cases of CAP caused by influenza virus or respiratory syncytial virus. Currently, evidence-based supportive care is key to managing severe viral pneumonia. We discuss the evidence surrounding epidemiology, diagnosis, management, treatment, and prevention of viral pneumonia.

Idioma originalInglés estadounidense
PublicaciónSeminars in Respiratory and Critical Care Medicine
EstadoAceptado - 2024

Nota bibliográfica

Publisher Copyright:
© 2024 Thieme Medical Publishers, Inc.. All rights reserved.


Profundice en los temas de investigación de 'Viral Pneumonia: From Influenza to COVID-19'. En conjunto forman una huella única.

Citar esto